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Abstract The G-protein-coupled receptor (GPCR) family me-
diates a host of cell^cell communications upon activation by
diverse ligands. Numerous GPCRs have been shown to display
anatomically selective patterns of gene expression, however, our
understanding of the complexity of GPCR signaling within hu-
man tissues remains unclear. In an e¡ort to characterize global
patterns of GPCR signaling in the human body, microarray
analysis was performed on a large panel of tissues to monitor
the gene expression levels of the receptors as well as related
signaling and regulatory molecules. Analysis of the data re-
vealed complex signaling networks in many tissue types, with
tissue-speci¢c patterns of gene expression observed for the ma-
jority of the receptors and a number of components and regu-
lators of GPCR signaling.
* 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
G-protein-coupled receptors (GPCRs) constitute the largest
family of cell-surface proteins. A wide variety of extracellular
stimuli (such as hormones, chemokines, odorants, and neuro-
transmitters) signal through this receptor family. GPCRs for
which the natural ligands have been identi¢ed are referred to
as ‘known’ receptors, while those for which no natural ligands
have yet been found are referred to as ‘orphan’ receptors.
Upon binding of extracellular ligands, GPCRs interact with
GTP-binding proteins (G-proteins). G-proteins are heterotri-
meric complexes composed of an K, L, and Q subunit, each of
which has multiple isoforms [1]. Their interaction with
GPCRs results in the dissociation of the GK subunit from
the GLQ complex. The dissociated subunits may subsequently
inhibit or activate e¡ector enzymes that modulate secondary
signaling pathways [2,3]. Regulation of G-proteins by RGSs
(regulator of G-protein signaling) and GPCR tra⁄cking by
RAMPs (receptor activity modifying proteins) have also been
described as mechanisms of modulating receptor signaling
[4,5]. The various mechanisms of GPCR signaling likely allow
for the range of extracellular stimuli to selectively induce cel-
lular responses in target tissues. While the extent of diversity
in GPCR signaling is unclear, results from a number of stud-
ies illustrate the tendency for GPCR gene expression to be
enriched in particular tissues. Restricted tissue distribution
of GPCRs has frequently re£ected their physiological func-
tions, as is the case of the role for the central nervous system
(CNS)-enriched dopamine receptors in neurotransmission [6].
Assessment of the tissue distribution of GPCRs and related
signaling molecules may therefore clarify the complexity of
the molecular mechanisms by which receptors act to transduce
extracellular stimuli.
The sequencing of the human genome has brought new
avenues by which global approaches can be undertaken to
investigate the breadth of GPCR signaling. It is now esti-
mated that the GPCR superfamily consists of 600^1000 re-
ceptors [7]. The advent of microarray technology allows for a
large sampling of the receptor family to be performed. This
technology permits one to monitor the message levels of thou-
sands of genes simultaneously in a given sample [8,9]. In this
study, we have used a custom high-density oligonucleotide
microarray containing probes designed to measure the gene
expression levels of over 700 human GPCRs, along with a
number of molecules involved in GPCR signaling and regu-
lation. Evaluation of the transcriptional levels for these genes
across a large panel of tissues would thus provide a global
view of GPCR signaling in the human body. This custom
microarray, in addition, was designed to monitor gene expres-
sion levels in the mouse, a common model organism used to
study the function of human GPCRs. Comparative analysis of
the gene expression levels of putative ortholog GPCR pairs
across a panel of tissues may characterize the concordance in
receptor signaling between the two species.
2. Materials and methods
2.1. Sample information and preparation of total RNA
Gross dissections of brain tissues from normal human donors were
obtained from the Harvard Brain Tissue Resource Center (McLean
Hospital, Belmont, MA, USA) and Clinomics Biosciences (Frederick,
MD, USA). Selection of normal donors was based on gross and mi-
croscopic examinations of multiple brain regions that indicated unre-
markable pathology. Total RNA was extracted from brain tissues
with TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) following
the manufacturer’s protocol. The quality of total RNA was then as-
sessed using an Agilent 2100 bioanalyzer (visible absence of signi¢cant
28S and 18S band degradation) and by spectrophotometry. High-
quality total RNA derived from the same brain region of a minimum
of three donors was pooled in an e¡ort to avoid biological variability.
Total RNA from normal human peripheral tissues of multiple donors
was purchased from commercial sources. Stable cell lines were ac-
quired from American Type Culture Collection (Manassas, VA,
USA). Cells were cultured under recommended conditions to near
con£uence. Mouse tissues were dissected from 8^15 C57/BL6 mice
ages 8^10 weeks.
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2.2. Microarray procedure and data analysis
High-density oligonucleotide microarray analysis was performed
essentially as previously described [10] using the A¡ymetrix (Santa
Clara, CA, USA) GeneChip technology. A custom dual-species mi-
croarray was designed to contain probes that monitor the expression
of over 700 known, orphan, and olfactory-like human GPCRs. Addi-
tionally, probes for a comparable number of putative mouse ortholog
GPCRs were designed. Putative mouse ortholog receptors were iden-
ti¢ed by reciprocal BLAST searches. Probes for mediators and regu-
lators of GPCR signaling described in the literature were also in-
cluded. Microarray analysis of total RNA was performed in
duplicate for each sample.
GeneChip software MAS 5.0 was used to analyze the relative
abundance of labeled cRNA hybridized to the microarray from
the scanned image. A threshold signal (Avg. Di¡.) level was de¢ned
for human and mouse samples to call a gene transcript present
or detectable based on polymerase chain reaction (PCR) valida-
tion of the microarray data and the expression levels of genes reported
in the literature to be expressed in particular tissues. Tissues were
grouped based on functional similarity and classi¢ed as primary
and stable cell lines, adipose, endocrine, CNS, immune, reproduc-
tive, gastrointestinal, or other tissue types. Hierarchical cluster
analysis was performed on genes that were detected in at least one
tissue sample and di¡erentially expressed (ANOVA, Ps 0.05) by a
hierarchical clustering algorithm [11] using an average linkage method
[12].
2.3. Comparative analysis of human and mouse microarray data
A set of common human and mouse tissues were used for the
analysis. Receptors that were detected and di¡erentially expressed
(ratio of standard deviation to mean greater than 0.5) in at least
one of the common tissues from both human and mouse samples
were incorporated into the analysis. Retained ortholog pairs were
compared by Pearson’s correlation coe⁄cient.
2.4. PCR validation of microarray data
PCR validation was assessed for 87 receptors for which expression
was detected by microarray analysis in at least one of six selected
tissues. cDNA was synthesized from the total RNA samples pro¢led
following the same protocols used for microarray analysis. Primers
were designed with the nucleotide sequence used to devise the oligo-
nucleotides synthesized on the microarrays. For each receptor, PCR
was performed with 100 ng cDNA of the tissues that showed detect-
able receptor expression by microarray analysis (total of 120 reac-
tions). Reactions were scored based on successful ampli¢cation of
receptor fragments from each cDNA. The incidence of receptor ex-
pression as determined by microarray analysis was then assessed in
each of the reactions.
3. Results
3.1. GPCR detection by microarray analysis
The gene expression levels of over 400 known and orphan
receptors and approximately 300 olfactory-like receptors were
assayed using a high-density oligonucleotide microarray. Mi-
croarray analysis was performed on 80 CNS and peripheral
non-diseased tissues, as well as primary cells and stable cell
lines. Results from the microarray experiments were validated
by PCR of 87 receptors in six di¡erent tissues. GPCRs that
were detected by microarray analysis were successfully ampli-
¢ed by PCR 85% of the time, while 15% of the reactions
showed no expression (data not shown). Of the GPCRs as-
sayed, 373 receptors had detectable transcriptional levels in at
least one of the tissues pro¢led. The lack of detection of the
other receptors represented on the microarray may, in part, be
due to non-optimal probe design, inadequate pro¢ling of oth-
er tissue types and developmental stages, or signal dilution
caused by cell types present in the sample assayed that do
not express the receptor.
3.2. Hierarchical cluster analysis of expression data
Hierarchical cluster analysis of the 373 detected receptors
was performed to identify tissue-speci¢c patterns of GPCR
expression (Fig. 1A). Dendrogram representation of the sam-
ple clustering partitioned the tissues into neuronal and periph-
eral groupings. These data, not surprisingly, show a greater
similarity in GPCR expression patterns among neuronal tis-
sues relative to peripheral tissues. Most notably expressed
within the neuronal tissues was a cluster of 67 GPCRs.
Among these receptors were the dopamine, GABA, and
brain-speci¢c angiogenesis inhibitor receptors (Fig. 1B). Tis-
sue-speci¢c clusters of GPCR expression were also present in
a number of peripheral tissues. Immune-related sample pro-
¢les revealed a cluster of 65 enriched GPCRs, with a number
of selectively expressed receptors in eosinophils, neutrophils,
and natural killer cells. Prominent clusters of GPCRs were
additionally found in the pro¢les of the pancreas, liver, testes,
and adipose tissues. The speci¢city in receptor tissue distribu-
tion indicates that functionally related tissues share subsets of
GPCRs with overlapping expression, while other tissues hav-
ing specialized physiological functions express clusters of
GPCRs with more distinct expression patterns. Additionally,
a set of cultured primary and stable cell lines derived from
unrelated tissues (including neural progenitors and PC-3)
showed similar patterns of GPCR expression. Clustering of
these samples in the same dendrogram branch may indicate
that in vitro culturing environments may signi¢cantly modu-
late GPCR expression.
Cellular responses induced by GPCR activation are medi-
ated by a number of signaling and regulatory molecules. The
tissue distribution for over 100 expressed genes was therefore
examined by hierarchical cluster analysis to determine
whether particular mechanisms of GPCR signaling and regu-
lation are predominant in certain tissue types. Three promi-
nent gene clusters were identi¢ed in neuronal tissues, immune-
related cell and tissue types, and a set of peripheral tissues.
Among the gene clusters found were a set of 10 G-proteins
and eight RGSs enriched in neuronal tissues and ¢ve G-pro-
teins and three RGSs enriched in immune cell types (Fig. 1C,
upper and middle panels). Another set of genes found to be
enriched in the peripheral tissues contained RAMPs 1^3 as
well as two RGSs and two G-proteins (Fig. 1C, lower panel).
Approximately half of these peripheral tissues are adipose-
related samples, implying a signi¢cant regulatory role for
the genes in GPCR signaling within adipose tissues. Genes
that displayed ubiquitous expression with nominal tissue spec-
i¢city included dynamin2, the heavy and light polypeptide
chains of clathrin, and L-arrestin 1 and 2. L-arrestin 2, how-
ever, was more highly expressed in monocytes, eosinophils,
and neutrophils in comparison to the other tissues (data not
shown). Such patterns in tissue distribution imply broad em-
ployment of receptor internalization mediated by these genes.
3.3. Expression and enrichment of GPCRs
Further examination of the microarray data revealed that
nearly all tissues pro¢led expressed between 40 and 120 recep-
tors (Fig. 2A). The pancreas, followed by CNS tissues, had
the greatest number of expressed receptors, suggesting a high
degree of cellular regulation by GPCR signal transduction.
Approximately 210 of the detected receptors were expressed
in CNS tissues, alluding to the complexity of regulating neu-
ronal networks. Interestingly, a number of peripheral tissues
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Fig. 1. Hierarchical cluster analysis of gene expression in human tissues. Expression data for genes detected in at least one tissue were used for
hierarchical cluster analysis. Expression levels were normalized for each gene across all tissue samples (red, above median expression; black,
median expression; green, below median expression). Genes were clustered based on correlations in tissue distributions. Tissues were clustered
based on correlations in gene expression pro¢les. A: Dendrogram of tissue relations is generated using the expression pro¢les of 373 GPCRs.
Expression data from hierarchical cluster analysis of (B) a select set of GPCRs with respective UniGene numbers and (C) select clusters of sig-
naling and regulatory molecules are shown.
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Fig. 2. Expression and enrichment of GPCRs. A: Identi¢cation of the number of GPCRs expressed in tissue samples. GPCRs that were detected in each tissue were classi¢ed as known (ligand
identi¢ed), orphan (no ligand identi¢ed), or olfactory-like. B: Identi¢cation of the number of GPCRs enriched in individual tissues. GPCRs detected within each tissue that had greater than ¢ve-
fold above-median expression levels across all tissues were classi¢ed as described above. The total number of non-overlapping receptors found within related tissue types is represented for each































likewise expressed a large subset of GPCRs. In contrast, cul-
tured primary and stable cell lines trended towards having the
least number of expressed receptors. Classi¢cation of all ex-
pressed GPCRs revealed that 281 of these receptors were
known or orphan and 92 were olfactory-like. The majority
of the samples pro¢led displayed comparable percentages of
known and orphan receptors. Olfactory-like receptors gener-
ally composed 0^20% of the expressed GPCRs.
GPCRs whose expression is enriched in particular tissues
are postulated to play a speci¢c regulatory role related to
those tissues. Analysis of the relative expression levels of
GPCRs revealed that 66.5% of the detected receptors were
enriched ¢ve-fold or greater above median levels across all
tissues pro¢led (Fig. 2B). These enriched receptors were
largely comprised of known as well as orphan GPCRs. Few
of the enriched receptors were olfactory-like, most likely due
to their generally low gene expression levels. Tissues having
the greatest occurrence of enriched receptors included various
brain regions and immune cell types. The large number of
enriched receptors suggests the necessity for complex and se-
lective regulatory mechanisms in these tissues.
3.4. Comparative analysis of human and mouse GPCR
expression
E¡orts to identify the functional roles of GPCRs often rely
on the mouse as a model organism. A study of the concord-
ance in GPCR expression between mouse and human tissues
was conducted by microarray analysis. The dual-species cus-
tom microarray was used to monitor the gene expression lev-
els of over 600 putative orthologs to human GPCRs in a
panel of 71 mouse tissues. Of the mouse GPCRs assessed,
365 receptors were detectable in at least one tissue, with
most tissues expressing 50^70 GPCRs (data not shown). A
comparison of human and mouse receptor pro¢les was per-
formed across 26 common tissues for 128 putative ortholog
GPCR pairs having detectable and di¡erential expression lev-
els within those tissues. Analysis of the expression data re-
vealed that approximately half of the GPCRs had correlation
coe⁄cients of 0.6 or greater (Fig. 3A). A number of GPCRs
(including parathyroid hormone receptor 1, formyl peptide
receptor 1, dopamine receptor D2, and frizzled homolog 4)
displayed highly correlative expression patterns between
mouse and human tissues. Likewise, several receptors, such
as adrenergic L-3 receptor and adenosine A2B receptor, had
poor correlation coe⁄cients between samples (Fig. 3B). These
results indicate that while many GPCRs have relatively con-
served expression distributions in mice and humans, some
receptors may have divergent physiological functions in par-
ticular tissues.
4. Discussion
In this study, microarray analysis was employed to map the
tissue distribution of GPCR family members, e¡ector path-
way components, and regulator molecules. Analysis of a di-
verse panel of tissues was essential in obtaining an accurate
global perspective of GPCR signaling. Interrogation of the
expression data set has provided insights into the complexity
of cell^cell communication and responsiveness to environmen-
tal stimuli within various tissue types.
Data analysis revealed that of the receptors assayed, 373
were detected in at least one tissue or cell type. Among these
GPCRs, an unexpectedly large number of olfactory-like re-
ceptors were found to have broad patterns of tissue distribu-
tion. These results suggest a functional role for the receptors
outside the olfactory tract. A few other studies have likewise
reported the expression of olfactory-like receptors in the
brain, testes, and prostate [13^15]. It remains to be determined
whether the messages detected for olfactory-like receptors in
CNS and peripheral tissues are transcribed into functional
receptors. In fact, some reports approximate that 70% of ol-
factory receptors are pseudogenes [16,17]. However, Spehr et
al. has recently identi¢ed a functional role for an odorant
receptor in mediating human sperm chemotaxis [18]. Our re-
sults add to the growing body of evidence that olfactory-like
Fig. 3. Comparison of GPCR expression levels in human and
mouse tissues. A: Pearson’s correlation analysis was performed on
128 GPCRs across 26 common human and mouse tissues. The fre-
quency of correlation coe⁄cients is plotted. B: The expression levels
of two receptors, adrenergic L-3 receptor and adenosine A2b recep-
tor, with low concordance between mouse and human tissues are
shown.
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receptors have potentially broad functionality as opposed to
limited roles in olfaction detection.
Overall, the greatest number of expressed and enriched re-
ceptors was found among CNS tissues. The cellular complex-
ity of the CNS has long been viewed as requiring speci¢c and
tight regulation of neuronal activity, perhaps more so than
other tissue types. Indeed, many neurotransmitters have
been shown to modulate neuronal responses via GPCR signal-
ing mechanisms [19,20]. While individual CNS tissues ex-
pressed a large number of GPCRs, analysis of the microarray
data revealed detection of comparable receptor numbers in
many other tissue types. Likewise, the number of enriched
receptors, which presumably have speci¢c functional roles,
was similar in neuronal tissues, the pancreas, and immune-
related cell types. It is possible, however, that the number of
GPCRs expressed in neuronal cell types is underestimated due
to signal dilution caused by the heterogeneous nature of neu-
ronal tissues. This issue may be clari¢ed by current ap-
proaches of gene expression analysis at the cellular level using
laser-dissected neuronal cell types [21]. Our data therefore
suggest that much like CNS tissues, various other tissue types
may utilize highly complex networks of GPCR signaling to
regulate cellular activity.
Hierarchical cluster analysis of the GPCR expression data
also identi¢ed tissue types with similar receptor pro¢les as
well as those having unique patterns of GPCR expression.
This analysis revealed clusters of GPCRs enriched in many
of the tissues pro¢led. The most notable examples of such
GPCR clusters were found in the CNS and immune cell types,
indicating overlapping expression of receptor subsets within
similar tissue types. Additionally, pro¢les of the testis, pitui-
tary gland, stomach, and endothelial cell populations each
contained highly selective GPCR clusters. It may be inferred
that GPCRs in these clusters function to speci¢cally modulate
the activity of the specialized cell types within the tissues.
Interestingly, a cluster of GPCRs was found within a set of
cultured primary and stable cell lines. These receptors may be
up-regulated as a cellular response to in vitro culturing con-
ditions and thus possibly involved in proliferative or anti-ap-
optotic signaling pathways. This assertion supports previous
reports of G-proteins harboring transformation and cell pro-
liferation potential [22].
Hierarchical cluster analysis of mediator and regulator mol-
ecules of GPCR signaling has also identi¢ed clusters in gene
expression patterns. Signaling molecules enriched in CNS-
and immune-associated clusters included a number of RGS
proteins. RGS proteins rapidly turn o¡ GPCR signaling path-
ways by inactivating G-proteins [23]. Enrichment of RGS
proteins in neuronal and immune tissues therefore suggests
a need for tight regulation of cellular signaling. While neuro-
nal expression of RGS proteins has previously been reported
[24,25], the mechanism by which they inhibit GPCR signaling
is poorly understood. Extrapolation from the cluster analysis
implies that the G-proteins enriched in the CNS tissues may
be candidate substrates of these RGS proteins. For instance,
the concordance in gene expression suggests that GNAZ and
GNAO1 are likely substrates of RGS7. Similarly, in the im-
mune-related cluster, RGS19 may modulate the activity of
GNAI3. Within the cluster of genes found in peripheral tis-
sues were RAMPs 1^3. These recently identi¢ed GPCR-inter-
acting proteins have been shown to modulate receptor traf-
¢cking, glycosylation, and ligand-binding pocket [5]. Though
the range of receptors that interact with RAMPs remains un-
known, the high gene expression levels point to their func-
tional signi¢cance in these tissues, in particular adipose tis-
sues. Within each of the clusters, various isoforms of the K, L,
and Q G-protein subunits were also present. These results sug-
gest that the three subunits may each contribute to tissue-
speci¢c signaling mechanisms. Further examination of the reg-
ulation of the above-mentioned signaling and regulatory mol-
ecules under physiological conditions is warranted. Given
their tissue selectivity and contributions to GPCR signaling,
some of these molecules may develop into appealing therapeu-
tic targets.
Common mechanisms of GPCR regulation were also ob-
served across the panel of tissues. Dynamin2 as well as the
heavy and light polypeptide chains of clathrin and the L-ar-
restins were ubiquitously expressed in the pro¢led tissues.
These molecules are involved in the desensitization of acti-
vated GPCRs via receptor internalization [26^28]. The expres-
sion data therefore suggest that clathrin-dependent endocyto-
sis is a general feedback mechanism used to protect against
acute and chronic over-stimulation of GPCRs upon ligand
binding. Noteworthy are the enhanced expression levels of
L-arrestin 2 in monocytes, eosinophils, and neutrophils. Stud-
ies examining the roles of L-arrestin 1 and 2 in receptor in-
ternalization have indicated their varying a⁄nities for di¡er-
ent GPCRs [28]. The enriched gene expression of L-arrestin 2
may indicate a prominent role for it in the internalization of
receptors speci¢cally expressed in these immune cell types.
Finally, an assessment of the concordance in GPCR expres-
sion patterns between human and mouse tissues was per-
formed. Mouse models of human physiology and disease are
increasingly being employed to characterize the functional
roles of GPCRs and their natural ligands. The suitability of
a model organism for the study of human genes often, in part,
relies on the sequence homology between species. Our study
indicates that expression data should complement sequence
information when evaluating model organisms. Although
many receptors had good concordance in their expression
levels across mouse and human tissues, some GPCRs did
not show comparable patterns of expression. For example,
the adrenergic L-3 receptor displayed high concordance in
adipose tissue where it is known to stimulate lypolysis. Yet,
poor concordance in gene expression levels was seen in the
bladder, placenta, and ovary. The microarray data indicate
that, with respect to gene expression, the mouse may be a
suitable model for the study of many GPCRs. However, the
functional roles of certain receptors may not be conserved
between human and mouse in some tissue types.
In conclusion, results from this study reveal vast GPCR
signaling networks in many tissue types. Expression of numer-
ous GPCRs in most tissues suggests broad cellular sensitivity
to a host of extracellular stimuli. Furthermore, the expression
data support the notion of tissue-speci¢c mechanisms of
GPCR signaling and regulation. These results are in accor-
dance with a recent study by Vassilatis et al. [29], which sim-
ilarly detected unique GPCR expression pro¢les within vari-
ous tissues. Utilization of diverse mechanisms to transduce
GPCR signals likely allows for distinct rates and durations
of cellular responses required by various tissues. Understand-
ing of global patterns of GPCR signaling provides a step
towards elucidating receptor function and how their dysregu-
lation may result in human disorders. Such information o¡ers
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important insights into the identi¢cation of novel GPCRs as
therapeutic targets.
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